What biomarker confirms pyridoxine-dependent epilepsy?

Plasma alpha-aminoadipic semialdehyde (alpha-AASA) and pipecolic acid are diagnostic biomarkers; urine alpha-AASA measured by tandem mass spectrometry; ALDH7A1 gene sequencing confirms; biomarkers elevated even on pyridoxine treatment.

What pyridoxine dose is diagnostic and therapeutic?

Trial pyridoxine 100 mg IV during EEG: seizure cessation within 30-60 minutes is diagnostic; maintenance 30-100 mg/day oral lifelong; folinic acid 3-5 mg/kg/day added for better outcomes; pyridoxal-5-phosphate used when pyridoxine fails (PNPO deficiency is different condition).

Why does lysine restriction improve outcomes in PDE?

PDE from ALDH7A1 deficiency causes accumulation of piperideine-6-carboxylate (P6C) from lysine catabolism, which inactivates pyridoxal-5-phosphate (active vitamin B6); lysine restriction (1-1.5 g/kg/day in infants) combined with pyridoxine reduces P6C burden and improves cognition.

What is the intellectual disability risk in PDE?

Without treatment: severe intellectual disability; with pyridoxine alone: 65% of patients still have intellectual disability; with pyridoxine + lysine restriction + arginine supplementation: improved outcomes in 50-70%; early treatment (neonatal or even prenatal) is the strongest predictor of normal cognition.

What distinguishes PDE from other neonatal seizure causes?

PDE presents in first 24h of life with refractory tonic-clonic or myoclonic seizures unresponsive to phenobarbitol/phenytoin; pyridoxine responsiveness is diagnostic; distinguish from hypoxic-ischemic encephalopathy, intracranial hemorrhage, and metabolic disorders by neonatal metabolic screen.

Pyridoxine-Dependent Epilepsy Biomarker and Treatment Response

Calculates pyridoxine-dependent epilepsy (PDE) diagnostic biomarkers (plasma/urine alpha-aminoadipic semialdehyde), pyridoxine dose response, lysine restriction protocol, and long-term neurodevelopmental outcome prediction.

Use the full interactive calculator below, or

Related Calculators

Biotinidase Monitor

Medical Calculators

GLUT1 KD Monitor

Medical Calculators

Metabolic Syndrome Risk

Medical Calculators

Pyridoxine-Dependent Epilepsy Biomarker and Treatment Response

Related Calculators

Frequently Asked Questions

What biomarker confirms pyridoxine-dependent epilepsy?

What pyridoxine dose is diagnostic and therapeutic?

Why does lysine restriction improve outcomes in PDE?

What is the intellectual disability risk in PDE?

What distinguishes PDE from other neonatal seizure causes?